Comparative biodistribution of PAMAM dendrimers and HPMA copolymers in ovarian-tumor-bearing mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biomacromolecules

• Publication date

  2011-01-10

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/bm101046dPMID 21128624PMCID PMC3476841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect.

  2011cited by this paper
• HPMA copolymer-cyclic RGD conjugates for tumor targeting.

  2010cited by this paper
• HPMA copolymers: origins, early developments, present, and future.

  2010cited by this paper
• Structural and chemical aspects of HPMA copolymers as drug carriers.

  2010cited by this paper
• Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.

  2010cited by this paper
• Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture.

  2009cited by this paper
• Effects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates.

  2009cited by this paper
• Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery.

  2009cited by this paper
• Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.

  2008cited by this paper
• Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulation.

  2008cited by this paper
• Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.

  2007cited by this paper
• Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.

  2006cited by this paper
• Imaging Acute Renal Failure with Polyamine Dendrimer-Based MRI Contrast Agents

  2006cited by this paper
• Polymer conjugates as anticancer nanomedicines

  2006cited by this paper
• Dendrimer-protein interactions studied by tryptophan room temperature phosphorescence.

  2006cited by this paper
• Polymer conjugates: nanosized medicines for treating cancer.

  2006cited by this paper
• Effects of glomerular filtration rate on Ficoll sieving coefficients (theta) in rats.

  2006cited by this paper
• PAMAM dendrimer based macromolecules as improved contrast agents.

  2005cited by this paper
• Dendrimer Interactions with Hydrophobic Fluorescent Probes and Human Serum Albumin

  2005cited by this paper
• Dendrimers in biomedical applications--reflections on the field.

  2005cited by this paper
• Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

  2005cited by this paper
• Transepithelial and endothelial transport of poly (amidoamine) dendrimers.

  2005cited by this paper
• Selective tumor targeting by enhanced permeability and retention effect. Synthesis and antitumor activity of polyphosphazene-platinum (II) conjugates.

  2005cited by this paper
• Dendrimer biocompatibility and toxicity.

  2005cited by this paper
• Nano-sized MRI contrast agents with dendrimer cores.

  2005cited by this paper
• Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers.

  2005cited by this paper
• Extravasation of Poly(amidoamine) (pamam) Dendrimers Across Microvascular Network Endothelium

  2004cited by this paper
• Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability.

  2004cited by this paper
• The targeting of anionized polyvinylpyrrolidone to the renal system.

  2004cited by this paper
• The effect of polyamidoamine dendrimers on human erythrocyte membrane acetylcholinesterase activity.

  2004cited by this paper
• The dawning era of polymer therapeutics

  2003cited by this paper
• Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications.

  2003cited by this paper
• The influence of surface modification on the cytotoxicity of PAMAM dendrimers.

  2003cited by this paper
• Interactions between PAMAM dendrimers and bovine serum albumin.

  2003cited by this paper
• Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin.

  2002cited by this paper
• Renal tubular damage detected by dynamic micro-MRI with a dendrimer-based magnetic resonance contrast agent.

  2002cited by this paper
• Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

  2000cited by this paper
• HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action.

  2000cited by this paper
• Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers.

  1996cited by this paper

• Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation.

  2026cites this paper
• PEGylated Heterofunctional Dendrimers Enable Multivalent Diclofenac Delivery for ROS-Driven Anticancer Activity.

  2026cites this paper
• Liposomal particokinetics and intratumoral microdistribution: A quantitative reassessment of the enhanced permeability and retention effect.

  2026cites this paper
• Dual delivery of supramolecular nanoparticle-carried minicircle donor DNA with Cas9/gRNA improved HITI knock-in efficiency in X-linked juvenile retinoschisis.

  2025cites this paper
• HPMA nanomedicine: targeting cancer with precision.

  2025cites this paper
• Dendrimers for Drug Delivery: An Overview of its Classes, Synthesis, and Applications

  2024cites this paper
• Multimodal, PSMA-Targeted, PAMAM Dendrimer-Drug Conjugates for Treatment of Prostate Cancer: Preclinical Evaluation

  2024cites this paper
• Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review

  2023cites this paper
• An Evaluation of CXCR4 Targeting with PAMAM Dendrimer Conjugates for Oncologic Applications

  2022influential citation
• Optimal Physicochemical Properties of Antibody–Nanoparticle Conjugates for Improved Tumor Targeting

  2022cites this paper
• Synthesis, characterisation and evaluation of hyperbranched N-(2-hydroxypropyl) methacrylamides for transport and delivery in pancreatic cell lines in vitro and in vivo.

  2022cites this paper
• Emerging innovations in nano-enabled therapy against age-related macular degeneration: A paradigm shift.

  2021cites this paper
• Radiolabelling of nanomaterials for medical imaging and therapy.

  2021cites this paper
• Embracing nanomaterials' interactions with the innate immune system.

  2021cites this paper
• PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy.

  2021cites this paper
• Emerging innate biological properties of nano-drug delivery systems: A focus on PAMAM dendrimers and their clinical potential.

  2021cites this paper
• Pharmacokinetic considerations in design of dendrimer-based nanomedicines

  2020cites this paper
• Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach

  2020cites this paper
• Polymer nanomedicines.

  2020cites this paper
• A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids

  2020cites this paper
• Polymer-Drug Conjugate, a Potential Therapeutic to Combat Breast and Lung Cancer

  2020cites this paper
• A Group of Complexes Based on PAMAM and Quantum Dots Used in Clinical Immunoassays

  2020cites this paper
• Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer.

  2020cites this paper
• Evaluation of PSMA-Targeted PAMAM Dendrimer Nanoparticles in a Murine Model of Prostate Cancer.

  2019cites this paper
• Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

  2019cites this paper
• Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.

  2019cites this paper
• Surface modified G4 PAMAM dendrimers cross the blood-brain barrier following tail-vein injections in C57BL/6J mice.

  2019cites this paper
• Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer.

  2019cites this paper
• PET imaging of distinct brain uptake of a nanobody and similarly-sized PAMAM dendrimers after intra-arterial administration

  2019cites this paper
• Therapeutic implications of nanomedicine for ocular drug delivery.

  2019cites this paper
• Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies

  2018cites this paper
• Exploring the role of polymeric conjugates toward anti‐cancer drug delivery: Current trends and future projections

  2018cites this paper
• Cyclic peptide-poly(HPMA) nanotubes as drug delivery vectors: In vitro assessment, pharmacokinetics and biodistribution.

  2018cites this paper
• Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model

  2018cites this paper
• Cross-Linked and Biodegradable Polymeric System as a Safe Magnetic Resonance Imaging Contrast Agent.

  2018cites this paper
• Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful Nanomedicine

  2018cites this paper
• Comparative Endocytosis Mechanisms and Anticancer Effect of HPMA Copolymer- and PAMAM Dendrimer-MTCP Conjugates for Photodynamic Therapy.

  2017cites this paper
• Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents.

  2017cites this paper
• Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model

  2017cites this paper
• Stimuli-responsive biodegradable and gadolinium-based poly[N-(2-hydroxypropyl) methacrylamide] copolymers: their potential as targeting and safe magnetic resonance imaging probes.

  2017cites this paper
• Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome

  2017cites this paper
• FRET Imaging of Enzyme-Responsive HPMA Copolymer Conjugate.

  2017cites this paper
• Generation‐6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model

  2017cites this paper
• Silencing the roadblocks to effective triple-negative breast cancer treatments by siRNA nanoparticles.

  2017cites this paper
• The nanomaterial toolkit for neuroengineering

  2016cites this paper
• Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers

  2016cites this paper
• Anticancer nanoparticulate polymer‐drug conjugate

  2016cites this paper
• Analysis of nanoparticle delivery to tumours

  2016cites this paper
• Impact of PAMAM delivery systems on signal transduction pathways in vivo: Modulation of ERK1/2 and p38 MAP kinase signaling in the normal and diabetic kidney.

  2016cites this paper
• Morpholino-terminated dendrimer shows enhanced tumor pH-triggered cellular uptake, prolonged circulation time, and low cytotoxicity

  2016cites this paper
• Transepithelial Transport of PAMAM Dendrimers Across Isolated Human Intestinal Tissue.

  2015cites this paper
• Applications of Nanomaterials in Radiotherapy for Malignant Tumors.

  2015cites this paper
• Nanomaterial-based approaches for advancing neurotechnologies

  2015cites this paper
• Fluorescein labelled cationic carbosilane dendritic systems for biological studies

  2015cites this paper
• Molecular weight (hydrodynamic volume) dictates the systemic pharmacokinetics and tumour disposition of PolyPEG star polymers.

  2015cites this paper
• Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates.

  2015cites this paper
• PAMAM dendrimers: destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applications.

  2015cites this paper
• Polyamidoamine and polyglycerol; their linear, dendritic and linear-dendritic architectures as anticancer drug delivery systems.

  2015cites this paper
• Radiolabeling optimization and characterization of (68)Ga labeled DOTA-polyamido-amine dendrimer conjugate - Animal biodistribution and PET imaging results.

  2015cites this paper
• Cationic Polyamidoamine Dendrimers as Modulators of EGFR Signaling In Vitro and In Vivo

  2015cites this paper
• Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.

  2015cites this paper
• Dendrimers in oral drug delivery application: current explorations, toxicity issues and strategies for improvement.

  2015cites this paper
• Can metabolic impairments in experimental diabetes be cured with poly(amido)amine (PAMAM) G4 dendrimers? In the search for minimizing of the adverse effects of PAMAM administration.

  2014cites this paper
• Co-caged gold nanoclusters and methyl motifs lead to detoxification of dendrimers and allow cytosolic access for siRNA transfection.

  2014cites this paper
• Impact of the Enhanced Permeability and Retention (EPR) Effect and Cathepsins Levels on the Activity of Polymer-Drug Conjugates

  2014cites this paper
• Utilizing electrostatic interactions to facilitate F-18 radiolabeling of poly(amido)amine (PAMAM) dendrimers.

  2014cites this paper
• Oligo(ethylene glycol)-based thermosensitive dendrimers and their tumor accumulation and penetration.

  2014cites this paper
• Refilling drug delivery depots through the blood

  2014cites this paper
• Nanoparticle toxicity assessment using an in vitro 3-D kidney organoid culture model.

  2014cites this paper
• FRET Imaging Trackable Long-Circulating Biodegradable Nanomedicines for Ovarian Carcinoma Therapy

  2014cites this paper
• Hybrid polyglycerols with long blood circulation: synthesis, biocompatibility, and biodistribution.

  2014cites this paper
• Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest

  2014cites this paper
• Mono(pyridine-N-oxide) DOTA analog and its G1/G4-PAMAM dendrimer conjugates labeled with 177Lu: radiolabeling and biodistribution studies.

  2014cites this paper
• Synthesis, biodistribution, and imaging of PEGylated-acetylated polyamidoamine dendrimers.

  2014cites this paper
• Synthesis and Properties of a Biodegradable Dendritic Magnetic Resonance Imaging Contrast Agent

  2014cites this paper
• Enzyme-activated nanoconjugates for tunable release of doxorubicin in hepatic cancer cells.

  2013cites this paper
• Synthetic Lipid Nanoparticles Targeting Steroid Organs

  2013cites this paper
• Polymer-based cancer nanotheranostics: retrospectives of multi-functionalities and pharmacokinetics.

  2013cites this paper
• Comparative pharmacokinetics of PAMAM-OH dendrimers and HPMA copolymers in ovarian tumor-bearing mice

  2013influential citation
• Polymeric micelles for solubilization and targeting of hydrophobic drugs

  2013cites this paper
• Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.

  2013cites this paper
• Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.

  2013cites this paper
• Macromolecular MRI contrast agents: Structures, properties and applications

  2013cites this paper
• Plasmonic photothermal therapy increases the tumor mass penetration of HPMA copolymers.

  2013cites this paper
• Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.

  2012cites this paper
• HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.

  2012cites this paper
• Improved delivery of polymer therapeutics to prostate tumors using plasmonic photothermal therapy

  2012cites this paper
• Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery.

  2012cites this paper
• Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution.

  2012cites this paper
• Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration.

  2012cites this paper
• Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.

  2011cites this paper
• Radiolabeling of PAMAM dendrimers conjugated to a pyridine-N-oxide DOTA analog with ¹¹¹In: Optimization of reaction conditions and biodistribution.

  2011cites this paper
• Targeted photodynamic therapy — a promising strategy of tumor treatment

  2011cites this paper
• Biologically optimized nanosized molecules and particles: more than just size.

  2011cites this paper
• Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment

  2011cites this paper